Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Philip Morris
PM
|
+$245M |
| 2 |
KeyCorp
KEY
|
+$199M |
| 3 |
RTX Corp
RTX
|
+$183M |
| 4 |
EMC
EMC CORPORATION
EMC
|
+$170M |
| 5 |
Ralph Lauren
RL
|
+$167M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$245M |
| 2 |
US Bancorp
USB
|
+$216M |
| 3 |
Apple
AAPL
|
+$207M |
| 4 |
Visa
V
|
+$188M |
| 5 |
Bank of America
BAC
|
+$177M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 9.66% |
| 2 | Consumer Discretionary | 8.08% |
| 3 | Energy | 7.71% |
| 4 | Technology | 6.85% |
| 5 | Industrials | 5.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4051
CALL
Sonoco
SON
$5.76B
| $358K | ﹤0.01% |
9,200
+5,300
| +136% | +$201K |
|
|
MTOR
4052
CALL
DELISTED
MERITOR, Inc.
MTOR
| $358K | ﹤0.01% |
45,600
-8,300
| -15% | -$64.2K |
|
|
CYT
4053
CALL
DELISTED
CYTEC INDS INC
CYT
| $358K | ﹤0.01% |
8,800
-7,600
| -46% | -$295K |
|
|
ACCL
4054
DELISTED
Accelrys Inc
ACCL
| $358K | ﹤0.01% |
+36,334
| New | +$332K |
|
|
ACOR
4055
CALL
DELISTED
Acorda Therapeutics
ACOR
| $357K | ﹤0.01% |
87
-11
| -11% | -$47.4K |
|
|
IMPV
4056
DELISTED
Imperva, Inc.
IMPV
| $357K | ﹤0.01% |
+8,495
| New | +$405K |
|
|
SKUL
4057
PUT
DELISTED
SKULLCANDY INC
SKUL
| $357K | ﹤0.01% |
57,800
-25,000
| -30% | -$140K |
|
4058
CALL
CBRE Group
CBRE
$44.3B
| $356K | ﹤0.01% |
15,400
-4,500
| -23% | -$104K |
|
|
RSTI
4059
DELISTED
Rofin-Sinar Technologies Inc
RSTI
| $356K | ﹤0.01% |
+14,707
| New | +$349K |
|
|
OSIR
4060
PUT
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $356K | ﹤0.01% |
21,400
+14,500
| +210% | +$214K |
|
|
AAWW
4061
PUT
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $355K | ﹤0.01% |
7,700
-19,700
| -72% | -$891K |
|
4062
Acadia Healthcare
ACHC
$2.87B
| $354K | ﹤0.01% |
+8,980
| New | +$333K |
|
4063
Cato Corp
CATO
$67.9M
| $354K | ﹤0.01% |
12,651
+2,047
| +19% | +$55.8K |
|
4064
PUT
Carpenter Technology
CRS
$27.1B
| $354K | ﹤0.01% |
6,100
-2,600
| -30% | -$139K |
|
4065
PUT
Diana Shipping
DSX
$309M
| $354K | ﹤0.01% |
41,909
-13,588
| -24% | -$104K |
|
4066
PUT
IMAX
IMAX
$2.9B
| $354K | ﹤0.01% |
11,700
-26,900
| -70% | -$724K |
|
|
MGLN
4067
PUT
DELISTED
Magellan Health Services, Inc.
MGLN
| $354K | ﹤0.01% |
5,900
-3,000
| -34% | -$174K |
|
|
EOCC
4068
DELISTED
Enel Generacion Chile S.A.
EOCC
| $354K | ﹤0.01% |
12,187
-26,977
| -69% | -$774K |
|
|
CNW
4069
CALL
DELISTED
CON-WAY INC.
CNW
| $353K | ﹤0.01% |
8,200
-2,800
| -25% | -$119K |
|
|
ELP
4070
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $352K | ﹤0.01% |
62,935
-456,755
| -88% | -$2.36M |
|
|
GES
4071
DELISTED
Guess Inc
GES
| $352K | ﹤0.01% |
+11,816
| New | +$369K |
|
4072
Quantum Corp
QMCO
$1.03B
| $352K | ﹤0.01% |
1,591
+774
| +95% | +$189K |
|
|
VOCS
4073
DELISTED
VOCUS INC
VOCS
| $352K | ﹤0.01% |
37,814
-101,629
| -73% | -$1.03M |
|
4074
Ennis
EBF
$559M
| $351K | ﹤0.01% |
19,461
-13,644
| -41% | -$249K |
|
|
MODV
4075
DELISTED
ModivCare
MODV
| $351K | ﹤0.01% |
12,232
-25,136
| -67% | -$707K |
|
Similar funds
Citadel Advisors's Q3 2013 Portfolio in Review
As of Q3 2013, Citadel Advisors held 7,215 positions worth $65.7B, up 13% from $58.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Citadel Advisors's Q3 2013 filing shows 735 new, 2,740 increased, 3,074 reduced and 505 closed positions. Its largest new stake was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M. The largest sale was Pfizer, an estimated $245M.
By sector, the portfolio is most concentrated in Financials at 9.7% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Energy.
- Citadel Advisors's largest Q3 2013 buy was ELAN CORP ADS(RP1 ORD4IRISH PN: 6,448,014 shares worth $100M.
- Citadel Advisors added most to Philip Morris in Q3 2013, an estimated $245M increase.
- Citadel Advisors's biggest Q3 2013 reduction was Pfizer, cutting an estimated $245M.
- Citadel Advisors fully exited NEWS CORPORATION CL-A in Q3 2013, selling an estimated $166M.
- Citadel Advisors's ten largest holdings make up 12% of its $65.7B portfolio in Q3 2013.
- Citadel Advisors opened 735 new positions and closed 505 in Q3 2013.
- Citadel Advisors's portfolio value rose 13% quarter-over-quarter to $65.7B.
Based on Citadel Advisors's 13F filing for Q3 2013, filed 14 Nov 2013.